Filing Flows › ARS Pharmaceuticals (SPRY) › Who owns the stock
Who owns ARS Pharmaceuticals (SPRY) stock
204 funds reported ARS Pharmaceuticals (SPRY) shares in their latest 13F filings, worth $741M in all. The largest holder is RA Capital Management, L.P. ($87.0M). Last quarter 102 funds added to their stakes and 78 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| RA Capital Management, L.P. | 10,860,977 | $87.0M | unchanged | 2026-06-30 |
| Rubric Capital Management LP | 8,540,861 | $68.4M | increase | 2026-06-30 |
| Orbimed Advisors LLC | 8,288,510 | $66.4M | unchanged | 2026-06-30 |
| Deerfield Management Company, L.P. (series C) | 7,503,812 | $60.1M | unchanged | 2026-06-30 |
| BlackRock | 5,311,319 | $42.5M | increase | 2026-06-30 |
| Vanguard Group | 3,509,174 | $40.9M | increase | 2025-12-31 |
| Tyro Capital Management LLC | 4,459,337 | $35.7M | increase | 2026-06-30 |
| abrdn | 4,170,629 | $33.4M | increase | 2026-06-30 |
| SR One Capital Management, LP | 4,012,903 | $32.1M | unchanged | 2026-06-30 |
| State Street | 3,730,623 | $29.9M | increase | 2026-06-30 |
| Capital World Investors | 2,754,931 | $22.1M | new | 2026-06-30 |
| Vanguard Capital Management LLC | 2,553,528 | $20.5M | increase | 2026-06-30 |
| Millennium Management LLC | 2,400,937 | $19.2M | decrease | 2026-06-30 |
| UBS Group AG | 1,939,654 | $15.5M | decrease | 2026-06-30 |
| Geode Capital Management, LLC | 1,699,017 | $13.6M | increase | 2026-06-30 |
ARS Pharmaceuticals' latest quarter
ARS Pharmaceuticals, Q3 2026: revenue $37.7M (+16% year over year), operating margin -90.6%, net loss $35.6M, operating cash flow −$33.7M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most SPRY stock?
By the latest 13F filings: RA Capital Management, L.P. ($87.0M); Rubric Capital Management LP ($68.4M); Orbimed Advisors LLC ($66.4M); Deerfield Management Company, L.P. (series C) ($60.1M); BlackRock ($42.5M).
What is the short interest in SPRY?
19,819,885 shares were sold short at the 2026-10-15 settlement, -6.47% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.